Female Synthetic Hormone Nafarelin Acetate (synarel) 76932-56-4 for Treating Endometriosis
- الصانع: Dewael
- الفحص المنتج: 99%+
- مظهر خارجي:White lyophilized powder
- مكان المنشأ: الصين
- شهادة: SGS,ISO9001، GMP
- أقل كمية ممكن طلبها: 100مل
- تفاصيل التعبئة: طرق سرية من التعبئة للجمارك تمرير مضمون
- موعد التسليم: في غضون 12 ساعة بعد تلقي دفعتك
- شروط الدفع: الاتحاد الغربي, موني جرام,بيتكوين,التحويل المصرفي
- الشحن: EMS,DHL,فيديكس,يو بي إس,TNT وهلم جرا.
- سياسات: إعادة شحن سياسة
- قدرة العرض: 500-600لتر / شهر
Female Synthetic Hormone Nafarelin Acetate (synarel) 76932-56-4 for Treating Endometriosis
Nafarelin Acetate (synarel) تفاصيل:
اسم المنتج | Nafarelin Acetate |
CAS NO. | 76932-56-4 |
المرادفات | Nafarelin Acetate |
Category | Pharmaceutical Raw Materials,Active Pharmaceutical Ingredients,Bulk Drugs,Fine Chemicals. |
نقاء | 99% Nafarelin Acetate |
مظهر خارجي | Nafarelin Acetate powder |
مدة الصلاحية | 2 years for Nafarelin Acetate |
استعمال | Nafarelin Acetate is used in female infertility and endometriosis. |
تخزين | Nafarelin Acetate should be stored in a well-closed containerat low temperature, keep away from moisture, heat and light. |
وصف
Its proposed mechanism of action could be the desensitization of pituitary GnRH receptors resulting in a decrease in gonadotropin release, and ovarian hormone serum concentrations much like those achieved in postmenopausal women. Nafarelin is administered by nasal inhalation and contains been generally well tolerated. It is associated with a high incidence of adverse effects but they are rarely severe enough to cause withdrawal from treatment, the ones occurring most frequently–hot flashes, vaginal dryness, and decreased libido–are a result of the hypoestrogenemia induced through the drug. Increased bone turnover is situated women on nafarelin but biochemical parameters resume pretreatment concentrations by six months after termination of treatment. This agent’s invest the therapy of endometriosis will be determined as clinical experience accumulates.
Nafarelin Acetate Application:
Treating endometriosis, including relieving pain and reducing lesions. It is usually used to treat early puberty (central precocious puberty [CPP]) in children of both sexes. It could be used for other difficulties as determined by your doctor.
Nafarelin is really a gonadotropin-releasing hormone (GnRH) agonist. It functions by decreasing creation of certain steroids in your body, which decreases the symptoms of endometriosis or early puberty.
COA
Item | تخصيص | Result |
مظهر خارجي | بودرة بيضاء | يتوافق |
تعريف | إيجابي | يتوافق |
فحص | 98.0% دقيقة | 98.2% |
Loss on Drying | 6.0%الأعلى. | 5.8% |
محتوى خلات(بواسطة HPLC) | 10.0%الأعلى. | 9.8% |
Peptide Content (ن%) | 80.0%دقيقة. | 88.0% |
Amino Acid Composition | ±10% of theoretical | يتوافق |
Single Impurity (HPLC) | 1.0%الأعلى. | 0.45% |
آنسة(إيسي) | Consistent | يتوافق |
Mass Balance | 95.0~105.0% | 98.0% |
———————————————————————————————————————————————————————————————————————————————————————-
اتصل الآن
التعليقات
لا توجد توصيات بعد.